Statistics

Total Visits

Views
Cost-effectiveness and cost-utility study of hypercholesterolemia treatment in Spain: evolocumab added to standard of care vs standard of care. 397

Total Visits Per Month

January 2024 February 2024 March 2024 April 2024 May 2024 June 2024 July 2024
Cost-effectiveness and cost-utility study of hypercholesterolemia treatment in Spain: evolocumab added to standard of care vs standard of care. 8 14 50 5 6 6 0

File Visits

Views
ImedioCerezoTFM.pdf 155

Top country views

Views
United States 145
Spain 76
Saudi Arabia 19
Hong Kong 10
Ireland 9
Barbados 8
France 8
Sweden 8
United Kingdom 7
Croatia 7

Top cities views

Views
Barcelona 20
San Ramon 15
Madrid 13
Blue Bell 11
Riyadh 11
Mountain View 10
Ashburn 9
Fremont 9
Bridgetown 8
Redwood City 8

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking